Related Experiment Video
Updated: Apr 30, 2026
06:57
In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
Published on: February 20, 2020
7.7K
Using humans to make a human leishmaniasis vaccine
Shaden Kamhawi1, Fabiano Oliveira, Jesus G Valenzuela
1Vector Molecular Biology Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA.
Science Translational Medicine
|May 3, 2014
Summary
Researchers identified key parts of Leishmania parasites in people immune to leishmaniasis. These findings help in developing a DNA vaccine against leishmaniasis.
Area of Science:
- Immunology
- Vaccinology
- Parasitology
Background:
- Leishmaniasis is a significant global health problem.
- Developing an effective vaccine against Leishmania is a priority.
Purpose of the Study:
- To identify T-cell epitopes from conserved Leishmania antigens.
- To inform the development of a human DNA vaccine for leishmaniasis.
Main Methods:
- Analysis of cellular immune response in leishmaniasis-immune individuals.
- Use of peptide pools from conserved Leishmania antigens.
Main Results:
- Identification of specific epitopes recognized by the immune system.
- Demonstration of a cellular immune response to conserved antigens.
Conclusions:
- The identified epitopes are promising targets for a DNA vaccine.
- This research contributes to the development of novel leishmaniasis vaccines.
